TH126308A - Pharmaceutical compounds and constituents for the treatment of viral infections - Google Patents
Pharmaceutical compounds and constituents for the treatment of viral infectionsInfo
- Publication number
- TH126308A TH126308A TH701006779A TH0701006779A TH126308A TH 126308 A TH126308 A TH 126308A TH 701006779 A TH701006779 A TH 701006779A TH 0701006779 A TH0701006779 A TH 0701006779A TH 126308 A TH126308 A TH 126308A
- Authority
- TH
- Thailand
- Prior art keywords
- constituents
- compounds
- treatment
- viral infections
- pharmaceutical compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 5
- 239000000470 constituent Substances 0.000 title abstract 4
- 208000036142 Viral infection Diseases 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 229940079593 drug Drugs 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 1
- 229960000367 inositol Drugs 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 abstract 4
- 208000019423 liver disease Diseases 0.000 abstract 2
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 2
- 230000000798 anti-retroviral effect Effects 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- -1 nucleoside derivative compounds Chemical class 0.000 abstract 1
Abstract
DC60 (27/09/54) ที่ให้ไว้ในที่นี้ คือ สารประกอบ, องค์ประกอบ และวิธีเพื่อบำบัดความผิดปกติของตับ, ซึ่งรวมถึง การติดเชื้อ HCV และ/หรือการติดเชื้อ HBV โดยเฉพาะเจาะจงแล้ว, สารประกอบ และ องค์ประกอบของอนุพันธ์นิวคลีโอไซด์ (nucleoside) ถูกเปิดเผย, ซึ่งสามารถให้อย่างเดียว หรือ ผสมผสานกันกับสารต้านไวรัสอื่น ที่ให้ไว้ในที่นี้ คือ สารประกอบ, องค์ประกอบ และวิธีเพื่อบำบัดความผิดปกติของตับ, ซึ่งรวมถึง การติดเชื้อ HCV และ/หรือการติดเชื้อ HBV โดยเฉพาะเจาะจงแล้ว, สารประกอบ และ องค์ประกอบของอนุพันธ์นิวคลีโอไซด์ (nucleoside) ถูกเปิดเผย, ซึ่งสามารถให้อย่างเดียว หรือ ผสมผสานกันกับสารต้านไวรัสอื่น สิทธิบัตรยา The DC60 (27/09/54) provided herein is the compounds, compositions and methods for treating liver disorders, which include HCV infection and / or specific HBV infection, its compounds and constituents. The presence of nucleoside derivatives, which can be given alone or in combination with other antiviral agents. The compounds, constituents and methods for treating liver disorders, including HCV infection and / or specific HBV infection, nucleoside derivative compounds and constituents are provided herein. (A nucleoside) was revealed, which can be given alone or in combination with another antiretroviral drug patent.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH126308A true TH126308A (en) | 2013-08-19 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE512973T1 (en) | NUCLEOSIDE ARYLPHOSPHORAMIDATES AND THEIR USE AS ANTIVIRAL AGENTS FOR THE TREATMENT OF HEPATITIS C VIRUS | |
| PH12015500749A1 (en) | 2`chloro nucleoside analogs for hcv infection | |
| NZ597544A (en) | Modified 4'-nucleosides as antiviral agents | |
| TW200630344A (en) | Tetracyclic indole derivatives as antiviral agents | |
| EA201171406A1 (en) | SPIROOXETANE DERIVATIVES OF URACIL-CONTAINING NUCLEOSIDE | |
| AR056850A1 (en) | METHODS AND KITS TO DOSAGE ANTIVIRAL NUCLEOSIDES BETA-D-2 ', 3'-DIDEHIDRO-2', 3 'DIDEOXI-5-FLUOROCITIDINE | |
| NO20091258L (en) | Entantiomerically pure phosphoindoles as HIV inhibitors | |
| CO6300958A2 (en) | IMIDAZOL NUCLEOSIDS [1,5-F] [1,2,4] TRIAZINIL, IMIDAZOL [1,2-F] 1,2,4] TRIAZINIL AND [1,2,4] TRIAZOLO [4,3-F] [1,2,4] TRIAZINIL FOR ANTIVIRAL TREATMENT. | |
| WO2007029029A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
| MX2009012433A (en) | Azido purine nucleosides for treatment of viral infections. | |
| TN2013000421A1 (en) | 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
| ME02321B (en) | Antiviral compounds | |
| MX2009012613A (en) | Heteroaryl substituted thiazoles and their use as antiviral agents. | |
| EA200970375A1 (en) | CONNECTIONS AND METHODS OF TREATMENT OF HEPATITIS C VIRUS | |
| WO2010068708A3 (en) | 3'-azido purine nucleotide prodrugs for treatment of viral infections | |
| SG136123A1 (en) | Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production | |
| DE602005018972D1 (en) | 5,6-DIMETHYLTHIENOE2,3-DIETYRIMIDIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF FOR THE FIGHT AGAINST VIRUSES | |
| TH126308A (en) | Pharmaceutical compounds and constituents for the treatment of viral infections | |
| TH150136A (en) | Hepatitis C virus inhibitors | |
| ME02294B (en) | Crystalline (s)-isopropyl 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin- 1-(2h)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy) (phenoxy)phosphoryl)amino)propanoate | |
| TH124704A (en) | Pharmaceutical compounds and constituents For treating viral infections | |
| TH124666A (en) | Spirocyclic proline and their use to treat HCV infection | |
| TH83065A (en) | Tetra cyclic derivatives Indole as an antiviral agent |